Renal Function Loss after Cryoablation of Small Renal Masses in Solitary Kidneys: European Registry for Renal Cryoablation Multi-Institutional Study

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

DOI

  • Seshadri Sriprasad, Dartford and Gravesend NHS Trust
  • ,
  • Mohammed Aldiwani, Dartford and Gravesend NHS Trust
  • ,
  • Shiv Pandian, Dartford and Gravesend NHS Trust
  • ,
  • Tommy K. Nielsen
  • Mohamed Ismail, North Bristol NHS Trust, Portsmouth Hospitals NHS Trust
  • ,
  • Neil J. Barber, Frimley Park Hospital NHS Foundation Trust
  • ,
  • Giovanni Lughezzani, IRCCS San Raffaele Scientific Institute
  • ,
  • Alessandro Larcher, IRCCS San Raffaele Scientific Institute
  • ,
  • Brunolf W. Lagerveld, Onze Lieve Vrouwe Gasthuis (OLVG)
  • ,
  • Francis X. Keeley, North Bristol NHS Trust

Objectives: To estimate and quantify the loss of kidney function in solitary kidneys with small renal masses (SRMs) after laparoscopy-assisted renal cryoablation (LARC), from the European Registry for Renal Cryoablation (EuRECA) database. Patients and Methods: Of the 808 patients from eight European centers in the database, 102 patients had SRMs in solitary kidneys. Patient demographics, body mass index (BMI), American Society of Anesthesiologists (ASA) grade, Charlson comorbidity index, and tumor characteristics including nephrometry (PADUA) score where available were collected. Renal function data in the form of estimated glomerular filtration rate (eGFR) and chronic kidney disease (CKD) stratification both preoperatively and at 3 months postoperatively were collected. Results: The median (interquartile range [IQR]) age was 67 (59-81) years, the median (IQR) BMI was 26 (23.9-28.9) kg/m2, and the median (IQR) ASA score was 2 (2-3). The median Charlson score was 4 (range: 0-10). The median (IQR) tumor size in cross-sectional imaging was 26 (19-38) mm. The follow-up data were available for 72 patients with a median follow-up for this group of 38 (range: 10-132) months. The mean preoperative eGFR was 55.0 mL/minute/1.73 m2 (standard deviation [SD] = 18.1), and the mean postoperative eGFR was 51.8 mL/minute/1.73 m2 (SD = 18.8). The change was -3.1 mL/minute/1.73 m2 (95% confidence interval -5.2 to -1.0) units, which was statistically significant (p = 0.004). The change in the CKD stages comparing before and after LARC was not significant (paired two-tailed t-test, p = 0.06). Critically, the decrease in the eGFR did not translate to any significant adverse outcome and zero patients required dialysis. Conclusion: To the best of our knowledge, this is the largest study of renal function after LARC in SRMs in solitary kidneys. Cryotherapy in this imperative situation is safe, carries clinically insignificant reduction in renal function, therefore providing an option to minimize the risk of developing renal failure necessitating dialysis.

OriginalsprogEngelsk
TidsskriftJournal of Endourology
Vol/bind34
Nummer2
Sider (fra-til)233-239
Antal sider7
ISSN0892-7790
DOI
StatusUdgivet - feb. 2020

Se relationer på Aarhus Universitet Citationsformater

ID: 182522330